Flaminia Vena

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

Physical and emotional abuse with internet addiction and anxiety as a mediator and physical activity as a moderator

Hyperechogenic fetal bowel: Current evidence‐based prenatal diagnosis and management

A focus on recent cases of suicides among Italian children and adolescents and a review of literature